Gastrointestinal Endoscopy Devices Market by Product Type (Accessories, Endoscopes, Operative Devices), Reusability (Reusable Endoscopes, Single-use Endoscopes), Age Group, Application, End User - Global Forecast 2025-2032
Description
The Gastrointestinal Endoscopy Devices Market was valued at USD 15.22 billion in 2024 and is projected to grow to USD 16.07 billion in 2025, with a CAGR of 5.91%, reaching USD 24.10 billion by 2032.
An authoritative introduction describing how clinical needs, device innovation, and health system priorities converge to redefine gastrointestinal endoscopy device utilization
Gastrointestinal endoscopy devices are central to contemporary digestive healthcare, enabling diagnosis, visualization, and minimally invasive therapy across a breadth of clinical scenarios. The expanding clinical indications for endoscopic intervention, the refinement of imaging and instrument design, and the parallel rise in single-use technologies have collectively reshaped how clinicians and health systems approach gastrointestinal care. This introduction situates the reader at the confluence of clinical need, device innovation, and health system transformation, setting the foundation for the subsequent analysis.
Across acute care hospitals, ambulatory facilities, and specialty clinics, endoscopy tools now serve roles that extend well beyond traditional diagnostic scopes into complex therapeutic procedures. Advancements in high-definition optics, integrated video processing, and instrument ergonomics have increased procedural precision and reduced complications, while sterilization protocols and lifecycle management for reusable platforms have come under renewed scrutiny. As clinical teams emphasize value-based outcomes, procurement and clinical governance leaders must reconcile device performance, patient safety, and procedural efficiency when selecting and deploying endoscopy solutions.
A nuanced exploration of the technological, regulatory, and care delivery forces reshaping gastrointestinal endoscopy practice and competitive dynamics
The gastrointestinal endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and operational forces. High-resolution imaging and real-time video processing have elevated diagnostic sensitivity, while ancillary device miniaturization and improved instrument control have expanded the therapeutic frontier. In parallel, regulatory emphasis on infection prevention and reusable instrument lifecycle management has accelerated the adoption of disposable platforms in settings seeking to reduce cross-contamination risk and streamline reprocessing workloads.
Economic pressures and evolving care delivery models further amplify these shifts. Care migration toward ambulatory surgery centers and specialty clinic networks emphasizes throughput and cost efficiency, favoring devices that reduce turnover time and support streamlined workflows. Meanwhile, digital integration-spanning cloud-enabled image storage, AI-assisted lesion detection, and interoperable procedural documentation-has begun to alter clinical workflows, enabling faster clinical decision-making and more consistent quality assurance across diverse practice settings. Together, these change vectors are pushing manufacturers and providers to innovate across the continuum of product development, clinical validation, and lifecycle service models.
A strategic assessment of how 2025 tariff changes are reshaping procurement, manufacturing footprint decisions, and supplier collaboration across the endoscopy value chain
Tariff policy adjustments introduced in 2025 have introduced a new layer of complexity for manufacturers, distributors, and healthcare purchasers engaged in the gastrointestinal endoscopy ecosystem. Higher import duties on select medical device categories have affected procurement strategies, compelling supply chain teams to evaluate regional sourcing, inventory buffering, and total landed cost implications. These dynamics have prompted some device vendors to reevaluate manufacturing footprints and supplier contracts to preserve margin structures and maintain competitive pricing for end users.
For health systems and ambulatory providers, tariff-induced cost inflation has necessitated closer collaboration with manufacturers on value-based contracting, flexible payment terms, and alternative procurement models such as consignment or managed inventory. Clinical operations have responded by prioritizing devices that demonstrate clear lifecycle efficiencies, including reduced reprocessing burdens or demonstrable improvements in procedure throughput. In this environment, companies that can localize production, offer predictable supply commitments, and provide compelling evidence of operational savings will be better positioned to sustain adoption despite the headwinds introduced by the 2025 tariff environment.
An integrated segmentation analysis revealing how product classes, reusability models, patient cohorts, clinical applications, and end‑user settings determine procurement and adoption drivers
Segmentation insight reveals a layered market structure that aligns closely with clinical workflows and procurement decision criteria. Based on product type, the ecosystem includes Accessories, Endoscopes, Operative Devices, and Visualization Equipment, where Accessories encompass components such as cameras, guide wires, and insertion tubes; Endoscopes cover both flexible and rigid designs tailored to anatomical and procedural requirements; Operative Devices are represented by forceps, scissors, and snares that enable a wide range of therapeutic interventions; and Visualization Equipment comprises cameras, light sources, monitors, and video processors that together form the imaging backbone of contemporary endoscopy suites.
Considering reusability, the market is divided between Reusable Endoscopes and Single-use Endoscopes, with each pathway presenting distinct trade-offs for infection control, capital expenditure, and operational throughput. Age group segmentation differentiates Adults, Geriatrics, and Pediatrics, highlighting how device ergonomics, channel dimensions, and procedural protocols must adapt to physiological variations across patient cohorts. Application-driven distinctions between Diagnostics and Therapeutics illuminate investment priorities: diagnostic imaging and lesion detection emphasize image quality and image analytics, while therapeutic use cases prioritize instrument precision and accessory compatibility. Finally, end user categorization across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics underscores the importance of workflow integration, procedural volume economics, and support services in procurement and adoption decisions. These intersecting segmentation axes inform product design priorities, commercial go-to-market approaches, and clinical adoption roadmaps.
A regional perspective describing how demand, regulation, infrastructure, and procurement diversity drive differentiated adoption patterns across key global markets
Regional dynamics continue to shape competitive positioning, regulatory pathways, and investment priorities across the global endoscopy landscape. In the Americas, demand drivers include the concentration of high-volume tertiary centers, an established ambulatory care sector, and payer systems that increasingly reward outcomes and efficiency, which together create strong incentives for devices that demonstrate procedural improvements and cost containment. Procurement cycles in this region tend to emphasize clinical evidence, service coverage, and direct vendor partnerships that can support rapid deployment and user training.
In Europe, Middle East & Africa, heterogeneous regulatory environments and variable healthcare infrastructure create a spectrum of adoption patterns, from early uptake of advanced imaging solutions in tertiary centers to targeted investments in cost-effective, single-use options in settings where reprocessing capacity is limited. Regionally specific reimbursement frameworks and centralized procurement arrangements can accelerate adoption in some markets while constraining it in others. In the Asia-Pacific region, rapid hospital expansion, increasing procedural volumes, and a growing focus on minimally invasive care are driving demand for both high-performance reusable systems and flexible single-use platforms. Local manufacturing partnerships and regulatory harmonization efforts in several Asia-Pacific markets are also influencing vendor strategies and speed to market.
A corporate and competitive overview highlighting how innovation strategies, partnerships, and service ecosystems create differentiation in the gastrointestinal endoscopy market
Competitive and corporate dynamics within the gastrointestinal endoscopy device sector are defined by a mix of incremental innovation, targeted acquisitions, and cross-sector partnerships. Leading manufacturers continue to invest in optical clarity, ergonomic design, and integrated digital capabilities, while specialist firms focus on narrow therapeutic niches and accessory development. Strategic collaborations between device makers and software companies are increasingly common, enabling enhanced imaging workflows, procedural documentation, and nascent artificial intelligence applications that support lesion detection and quality metrics.
Consolidation activity remains a salient theme as established firms seek to broaden portfolios and access differentiated technologies, while smaller innovators pursue clinical validation and scale through distribution alliances. Aftermarket services including training, reprocessing support, and maintenance contracts have become meaningful differentiators in buyer decisions, prompting vendors to bundle service offerings with capital equipment. Companies that combine robust clinical evidence generation, comprehensive service ecosystems, and flexible commercial terms are demonstrating higher resilience in competitive tenders and integrated procurement processes.
Actionable recommendations for product strategy, commercial models, and supply chain resilience to drive sustainable adoption and clinical value in endoscopy programs
Industry leaders should prioritize a balanced roadmap that aligns product development with operational realities and evolving clinical priorities. Investing in interoperable visualization platforms that support high-definition imaging, standardized procedural documentation, and modular accessory compatibility will ease integration into varied clinical environments and extend product longevity. At the same time, developing single-use options as part of a hybrid portfolio can address immediate infection control concerns while preserving reusable platforms for high-volume procedures where lifecycle economics and performance advantages remain compelling.
Commercially, vendors should pursue flexible contracting models that account for total cost of ownership and offer meaningful service commitments, including training and reprocessing support. Manufacturers must also consider regional manufacturing or contract production to reduce exposure to tariff volatility and support more predictable supply chains. Clinicians and health system procurement leaders should collaborate early in the product evaluation process, using structured clinical validation and operational pilots to quantify workflow impacts and inform scaled adoption. Finally, continued investment in real-world evidence and user-centered design will accelerate clinical acceptance and create defensible value propositions in increasingly cost-conscious markets.
A transparent mixed‑methods research approach combining primary clinical and procurement interviews with secondary regulatory and technical evidence to generate actionable insights
The research methodology integrates quantitative device and procedure-level data with qualitative insights from clinical leaders, supply chain professionals, and industry executives to produce a balanced and actionable analysis. Primary data collection involved structured interviews with stakeholders across hospitals, ambulatory surgery centers, and specialty clinics to capture front-line operational challenges, device preferences, and procurement considerations. Secondary research drew on regulatory filings, clinical literature, and device performance reports to contextualize technology trends and clinical efficacy discussions.
Analytical approaches prioritized triangulation across sources, ensuring that manufacturing, regulatory, and clinical signals were reconciled against practitioner experience and procurement realities. Scenario analysis assessed the operational consequences of evolving reuse policies and tariff impacts without invoking market sizing or forecasting. Throughout, emphasis was placed on reproducibility and transparency in data handling, with clear documentation of interview protocols, inclusion criteria for secondary sources, and methods for synthesizing multi-source evidence into strategic insights.
A concise conclusion synthesizing how innovation, operational priorities, and policy dynamics converge to influence adoption and competitive advantage in endoscopy devices
In sum, the gastrointestinal endoscopy device landscape sits at a pivotal juncture where clinical innovation, operational efficiency, and policy changes intersect to influence procurement and adoption. Technological advances in imaging and instrumentation, the rise of single-use technologies alongside refined reusable platforms, and shifting care delivery models collectively shape decision levers for providers and manufacturers alike. The net effect is a market environment that rewards demonstrable clinical value, operational robustness, and supply chain agility.
Stakeholders that synthesize clinical priorities with pragmatic procurement strategies-coupled with targeted investments in evidence generation and service delivery-are most likely to translate innovation into sustained clinical and commercial outcomes. As healthcare systems continue to balance safety, cost, and access objectives, device makers and providers who proactively align design, validation, and support services will gain meaningful advantage in facilitating better patient care and optimized operational performance.
Please Note: PDF & Excel + Online Access - 1 Year
An authoritative introduction describing how clinical needs, device innovation, and health system priorities converge to redefine gastrointestinal endoscopy device utilization
Gastrointestinal endoscopy devices are central to contemporary digestive healthcare, enabling diagnosis, visualization, and minimally invasive therapy across a breadth of clinical scenarios. The expanding clinical indications for endoscopic intervention, the refinement of imaging and instrument design, and the parallel rise in single-use technologies have collectively reshaped how clinicians and health systems approach gastrointestinal care. This introduction situates the reader at the confluence of clinical need, device innovation, and health system transformation, setting the foundation for the subsequent analysis.
Across acute care hospitals, ambulatory facilities, and specialty clinics, endoscopy tools now serve roles that extend well beyond traditional diagnostic scopes into complex therapeutic procedures. Advancements in high-definition optics, integrated video processing, and instrument ergonomics have increased procedural precision and reduced complications, while sterilization protocols and lifecycle management for reusable platforms have come under renewed scrutiny. As clinical teams emphasize value-based outcomes, procurement and clinical governance leaders must reconcile device performance, patient safety, and procedural efficiency when selecting and deploying endoscopy solutions.
A nuanced exploration of the technological, regulatory, and care delivery forces reshaping gastrointestinal endoscopy practice and competitive dynamics
The gastrointestinal endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and operational forces. High-resolution imaging and real-time video processing have elevated diagnostic sensitivity, while ancillary device miniaturization and improved instrument control have expanded the therapeutic frontier. In parallel, regulatory emphasis on infection prevention and reusable instrument lifecycle management has accelerated the adoption of disposable platforms in settings seeking to reduce cross-contamination risk and streamline reprocessing workloads.
Economic pressures and evolving care delivery models further amplify these shifts. Care migration toward ambulatory surgery centers and specialty clinic networks emphasizes throughput and cost efficiency, favoring devices that reduce turnover time and support streamlined workflows. Meanwhile, digital integration-spanning cloud-enabled image storage, AI-assisted lesion detection, and interoperable procedural documentation-has begun to alter clinical workflows, enabling faster clinical decision-making and more consistent quality assurance across diverse practice settings. Together, these change vectors are pushing manufacturers and providers to innovate across the continuum of product development, clinical validation, and lifecycle service models.
A strategic assessment of how 2025 tariff changes are reshaping procurement, manufacturing footprint decisions, and supplier collaboration across the endoscopy value chain
Tariff policy adjustments introduced in 2025 have introduced a new layer of complexity for manufacturers, distributors, and healthcare purchasers engaged in the gastrointestinal endoscopy ecosystem. Higher import duties on select medical device categories have affected procurement strategies, compelling supply chain teams to evaluate regional sourcing, inventory buffering, and total landed cost implications. These dynamics have prompted some device vendors to reevaluate manufacturing footprints and supplier contracts to preserve margin structures and maintain competitive pricing for end users.
For health systems and ambulatory providers, tariff-induced cost inflation has necessitated closer collaboration with manufacturers on value-based contracting, flexible payment terms, and alternative procurement models such as consignment or managed inventory. Clinical operations have responded by prioritizing devices that demonstrate clear lifecycle efficiencies, including reduced reprocessing burdens or demonstrable improvements in procedure throughput. In this environment, companies that can localize production, offer predictable supply commitments, and provide compelling evidence of operational savings will be better positioned to sustain adoption despite the headwinds introduced by the 2025 tariff environment.
An integrated segmentation analysis revealing how product classes, reusability models, patient cohorts, clinical applications, and end‑user settings determine procurement and adoption drivers
Segmentation insight reveals a layered market structure that aligns closely with clinical workflows and procurement decision criteria. Based on product type, the ecosystem includes Accessories, Endoscopes, Operative Devices, and Visualization Equipment, where Accessories encompass components such as cameras, guide wires, and insertion tubes; Endoscopes cover both flexible and rigid designs tailored to anatomical and procedural requirements; Operative Devices are represented by forceps, scissors, and snares that enable a wide range of therapeutic interventions; and Visualization Equipment comprises cameras, light sources, monitors, and video processors that together form the imaging backbone of contemporary endoscopy suites.
Considering reusability, the market is divided between Reusable Endoscopes and Single-use Endoscopes, with each pathway presenting distinct trade-offs for infection control, capital expenditure, and operational throughput. Age group segmentation differentiates Adults, Geriatrics, and Pediatrics, highlighting how device ergonomics, channel dimensions, and procedural protocols must adapt to physiological variations across patient cohorts. Application-driven distinctions between Diagnostics and Therapeutics illuminate investment priorities: diagnostic imaging and lesion detection emphasize image quality and image analytics, while therapeutic use cases prioritize instrument precision and accessory compatibility. Finally, end user categorization across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics underscores the importance of workflow integration, procedural volume economics, and support services in procurement and adoption decisions. These intersecting segmentation axes inform product design priorities, commercial go-to-market approaches, and clinical adoption roadmaps.
A regional perspective describing how demand, regulation, infrastructure, and procurement diversity drive differentiated adoption patterns across key global markets
Regional dynamics continue to shape competitive positioning, regulatory pathways, and investment priorities across the global endoscopy landscape. In the Americas, demand drivers include the concentration of high-volume tertiary centers, an established ambulatory care sector, and payer systems that increasingly reward outcomes and efficiency, which together create strong incentives for devices that demonstrate procedural improvements and cost containment. Procurement cycles in this region tend to emphasize clinical evidence, service coverage, and direct vendor partnerships that can support rapid deployment and user training.
In Europe, Middle East & Africa, heterogeneous regulatory environments and variable healthcare infrastructure create a spectrum of adoption patterns, from early uptake of advanced imaging solutions in tertiary centers to targeted investments in cost-effective, single-use options in settings where reprocessing capacity is limited. Regionally specific reimbursement frameworks and centralized procurement arrangements can accelerate adoption in some markets while constraining it in others. In the Asia-Pacific region, rapid hospital expansion, increasing procedural volumes, and a growing focus on minimally invasive care are driving demand for both high-performance reusable systems and flexible single-use platforms. Local manufacturing partnerships and regulatory harmonization efforts in several Asia-Pacific markets are also influencing vendor strategies and speed to market.
A corporate and competitive overview highlighting how innovation strategies, partnerships, and service ecosystems create differentiation in the gastrointestinal endoscopy market
Competitive and corporate dynamics within the gastrointestinal endoscopy device sector are defined by a mix of incremental innovation, targeted acquisitions, and cross-sector partnerships. Leading manufacturers continue to invest in optical clarity, ergonomic design, and integrated digital capabilities, while specialist firms focus on narrow therapeutic niches and accessory development. Strategic collaborations between device makers and software companies are increasingly common, enabling enhanced imaging workflows, procedural documentation, and nascent artificial intelligence applications that support lesion detection and quality metrics.
Consolidation activity remains a salient theme as established firms seek to broaden portfolios and access differentiated technologies, while smaller innovators pursue clinical validation and scale through distribution alliances. Aftermarket services including training, reprocessing support, and maintenance contracts have become meaningful differentiators in buyer decisions, prompting vendors to bundle service offerings with capital equipment. Companies that combine robust clinical evidence generation, comprehensive service ecosystems, and flexible commercial terms are demonstrating higher resilience in competitive tenders and integrated procurement processes.
Actionable recommendations for product strategy, commercial models, and supply chain resilience to drive sustainable adoption and clinical value in endoscopy programs
Industry leaders should prioritize a balanced roadmap that aligns product development with operational realities and evolving clinical priorities. Investing in interoperable visualization platforms that support high-definition imaging, standardized procedural documentation, and modular accessory compatibility will ease integration into varied clinical environments and extend product longevity. At the same time, developing single-use options as part of a hybrid portfolio can address immediate infection control concerns while preserving reusable platforms for high-volume procedures where lifecycle economics and performance advantages remain compelling.
Commercially, vendors should pursue flexible contracting models that account for total cost of ownership and offer meaningful service commitments, including training and reprocessing support. Manufacturers must also consider regional manufacturing or contract production to reduce exposure to tariff volatility and support more predictable supply chains. Clinicians and health system procurement leaders should collaborate early in the product evaluation process, using structured clinical validation and operational pilots to quantify workflow impacts and inform scaled adoption. Finally, continued investment in real-world evidence and user-centered design will accelerate clinical acceptance and create defensible value propositions in increasingly cost-conscious markets.
A transparent mixed‑methods research approach combining primary clinical and procurement interviews with secondary regulatory and technical evidence to generate actionable insights
The research methodology integrates quantitative device and procedure-level data with qualitative insights from clinical leaders, supply chain professionals, and industry executives to produce a balanced and actionable analysis. Primary data collection involved structured interviews with stakeholders across hospitals, ambulatory surgery centers, and specialty clinics to capture front-line operational challenges, device preferences, and procurement considerations. Secondary research drew on regulatory filings, clinical literature, and device performance reports to contextualize technology trends and clinical efficacy discussions.
Analytical approaches prioritized triangulation across sources, ensuring that manufacturing, regulatory, and clinical signals were reconciled against practitioner experience and procurement realities. Scenario analysis assessed the operational consequences of evolving reuse policies and tariff impacts without invoking market sizing or forecasting. Throughout, emphasis was placed on reproducibility and transparency in data handling, with clear documentation of interview protocols, inclusion criteria for secondary sources, and methods for synthesizing multi-source evidence into strategic insights.
A concise conclusion synthesizing how innovation, operational priorities, and policy dynamics converge to influence adoption and competitive advantage in endoscopy devices
In sum, the gastrointestinal endoscopy device landscape sits at a pivotal juncture where clinical innovation, operational efficiency, and policy changes intersect to influence procurement and adoption. Technological advances in imaging and instrumentation, the rise of single-use technologies alongside refined reusable platforms, and shifting care delivery models collectively shape decision levers for providers and manufacturers alike. The net effect is a market environment that rewards demonstrable clinical value, operational robustness, and supply chain agility.
Stakeholders that synthesize clinical priorities with pragmatic procurement strategies-coupled with targeted investments in evidence generation and service delivery-are most likely to translate innovation into sustained clinical and commercial outcomes. As healthcare systems continue to balance safety, cost, and access objectives, device makers and providers who proactively align design, validation, and support services will gain meaningful advantage in facilitating better patient care and optimized operational performance.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Adoption of AI-enabled lesion detection systems to improve diagnostic accuracy and workflow efficiency in GI endoscopy
- 5.2. Rising utilization of disposable endoscopes to reduce cross-contamination risks and streamline sterilization processes
- 5.3. Integration of high-definition and narrow-band imaging technologies for enhanced mucosal visualization and early disease detection
- 5.4. Development of ultrathin transnasal endoscopes for improved patient comfort and expanded outpatient procedure adoption
- 5.5. Expansion of robotics-assisted endoscopic platforms for precise therapeutic interventions in complex GI procedures
- 5.6. Growing emphasis on telemonitoring and remote proctoring solutions to extend specialist reach in rural and underserved areas
- 5.7. Advancements in single-use biopsy and resection tools for minimally invasive tissue sampling during GI endoscopy
- 5.8. Increasing demand for 3D and fluorescence imaging modalities to aid real-time tumor margin assessment and guided biopsies
- 5.9. Emergence of integrated waterjet irrigation and suction systems to maintain optimal visibility during prolonged endoscopic procedures
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Gastrointestinal Endoscopy Devices Market, by Product Type
- 8.1. Accessories
- 8.1.1. Cameras
- 8.1.2. Guide Wires
- 8.1.3. Insertion Tubes
- 8.2. Endoscopes
- 8.2.1. Flexible Endoscopes
- 8.2.2. Rigid Endoscopes
- 8.3. Operative Devices
- 8.3.1. Forceps
- 8.3.2. Scissors
- 8.3.3. Snares
- 8.4. Visualization Equipment
- 8.4.1. Cameras
- 8.4.2. Light Sources
- 8.4.3. Monitors
- 8.4.4. Video Processors
- 9. Gastrointestinal Endoscopy Devices Market, by Reusability
- 9.1. Reusable Endoscopes
- 9.2. Single-use Endoscopes
- 10. Gastrointestinal Endoscopy Devices Market, by Age Group
- 10.1. Adults
- 10.2. Geriatrics
- 10.3. Pediatrics
- 11. Gastrointestinal Endoscopy Devices Market, by Application
- 11.1. Diagnostics
- 11.2. Therapeutics
- 12. Gastrointestinal Endoscopy Devices Market, by End User
- 12.1. Ambulatory Surgery Centers
- 12.2. Hospitals
- 12.3. Specialty Clinics
- 13. Gastrointestinal Endoscopy Devices Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Gastrointestinal Endoscopy Devices Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Gastrointestinal Endoscopy Devices Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Abbott Laboratories
- 16.3.2. Ambu A/S
- 16.3.3. Becton, Dickinson and Company
- 16.3.4. Boston Scientific Corporation
- 16.3.5. Cardinal Health
- 16.3.6. ConMed Corporation
- 16.3.7. Cook Medical, Inc.
- 16.3.8. Erbe Elektromedizin GmbH
- 16.3.9. Fujifilm Holdings Corporation
- 16.3.10. Johnson & Johnson
- 16.3.11. KARL STORZ SE & Co. KG
- 16.3.12. Medtronic plc
- 16.3.13. MICRO-TECH (Nanjing) Co., Ltd.
- 16.3.14. Olympus Corporation
- 16.3.15. PENTAX Medical America, Inc.
- 16.3.16. Richard Wolf GmbH
- 16.3.17. SB-KAWASUMI LABORATORIES, INC.
- 16.3.18. Smart Medical Systems Ltd.
- 16.3.19. Smith & Nephew plc
- 16.3.20. STERIS plc
- 16.3.21. Stryker Corporation
- 16.3.22. Teleflex Incorporated
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
